But this, by far, isnt the first weight loss medication on the market, so you may wonder why you should try it
Investors are likely still spooked by the news that the Food and Drug Administration declared that semaglutide, the active ingredient in Novo Nordisks Ozempic and Wegovy, is no longer in a shortage, limiting Hims & Hers ability to make copycat versions
Following the proper injection procedure not only prevents site reactions, it can help prevent infection
It also has the most adults suffering from diabetes after China, according to the International Diabetes Federation
Hims & Hers said it expected revenue for the first quarter of 2025 to be between $520 million and $540 million, compared to the $497 million analysts had penciled in
Continue with your next scheduled dose at the normal time